{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:26:33Z","timestamp":1778570793572,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T00:00:00Z","timestamp":1463702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T00:00:00Z","timestamp":1463702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intrahepatic and extrahepatic metastases are frequently detected in hepatocellular carcinoma (HCC). Epithelial-mesenchymal transition (EMT) is believed to drive metastasis. There are not many well-established model systems to study EMT in HCC. Here we identified an atypical EMT while characterizing a population of mesenchymal cells in Huh7.5 hepatoma cell cultures. Cells with distinct morphology appeared during geneticin treatment of Huh7.5 cultures. Molecular characterization of geneticin resistant Huh7.5M cells confirmed EMT. Huh7.5M cells expressed cancer stem cell markers. p38MAPK and ERK1\/2 were substantially activated in Huh7.5M cells. Their Inhibition elevated E-Cadherin expression with concerted suppression of Vimentin and anchorage independent growth in Huh7.5M cells. TGF\u03b2 could not induce EMT in Huh7.5 cultures, but enriched mesenchymal populations, similar to geneticin. Huh7.5M cells formed more aggressive solid tumors, primarily comprising cells with epithelial morphology, in nude mice. Canonical EMT-TFs did not participate in this atypical EMT, indicating that the established canonical EMT-TFs do not drive every EMT and there is a dire need to identify additional factors. The system that we characterized is a unique model to study EMT, MET and biphasic TGF\u03b2 signaling in HCC and offers considerable potential to facilitate more insightful studies on deeper questions in tumor metastasis.<\/jats:p>","DOI":"10.1038\/srep26282","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T09:45:53Z","timestamp":1463823953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["An Atypical System for Studying Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma"],"prefix":"10.1038","volume":"6","author":[{"given":"Dhiviya","family":"Vedagiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiren Vasantrai","family":"Lashkari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abubakar Siddiq","family":"Mangani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerald Mahesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jedy","family":"Jose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avinash Raj","family":"Thatipalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnan Harinivas","family":"Harshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,20]]},"reference":[{"key":"BFsrep26282_CR1","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HB El-Serag","year":"2007","unstructured":"El-Serag, H. B. & Rudolph, K. L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557\u20132576 (2007).","journal-title":"Gastroenterology"},{"key":"BFsrep26282_CR2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/hep.23748","volume":"52","author":"W Ding","year":"2010","unstructured":"Ding, W. et al. Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology 52, 945\u2013953 (2010).","journal-title":"Hepatology"},{"key":"BFsrep26282_CR3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00000658-200007000-00003","volume":"232","author":"R Tung-Ping Poon","year":"2000","unstructured":"Tung-Ping Poon, R., Fan, S. T. & Wong, J. Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232, 10\u201324 (2000).","journal-title":"Ann Surg"},{"key":"BFsrep26282_CR4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2, 442\u2013454 (2002).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep26282_CR5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","volume":"9","author":"K Polyak","year":"2009","unstructured":"Polyak, K. & Weinberg, R. A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9, 265\u2013273 (2009).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep26282_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-cellbio-092910-154036","volume":"27","author":"MA Nieto","year":"2011","unstructured":"Nieto, M. A. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 27, 347\u2013376 (2011).","journal-title":"Annu Rev Cell Dev Biol"},{"key":"BFsrep26282_CR7","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J Clin Invest 119, 1420\u20131428 (2009).","journal-title":"J Clin Invest"},{"key":"BFsrep26282_CR8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704\u2013715 (2008).","journal-title":"Cell"},{"key":"BFsrep26282_CR9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871\u2013890 (2009).","journal-title":"Cell"},{"key":"BFsrep26282_CR10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.1228522","volume":"339","author":"M Yu","year":"2013","unstructured":"Yu, M. et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science (New York, N.Y.) 339, 580\u2013584 (2013).","journal-title":"Science (New York, N.Y.)"},{"key":"BFsrep26282_CR11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2131","volume":"7","author":"H Peinado","year":"2007","unstructured":"Peinado, H., Olmeda, D. & Cano, A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7, 415\u2013428 (2007).","journal-title":"Nat Rev Cancer"},{"key":"BFsrep26282_CR12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/35000025","volume":"2","author":"A Cano","year":"2000","unstructured":"Cano, A. et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2, 76\u201383 (2000).","journal-title":"Nat Cell Biol"},{"key":"BFsrep26282_CR13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massague","year":"2012","unstructured":"Massague, J. TGFbeta signalling in context. Nat Rev Mol Cell Biol 13, 616\u2013630 (2012).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFsrep26282_CR14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.semcancer.2012.04.002","volume":"22","author":"A Moustakas","year":"2012","unstructured":"Moustakas, A. & Heldin, C. H. Induction of epithelial-mesenchymal transition by transforming growth factor beta. Semin Cancer Biol 22, 446\u2013454 (2012).","journal-title":"Semin Cancer Biol"},{"key":"BFsrep26282_CR15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000147748","volume":"154","author":"ED Hay","year":"1995","unstructured":"Hay, E. D. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 154, 8\u201320 (1995).","journal-title":"Acta Anat (Basel)"},{"key":"BFsrep26282_CR16","doi-asserted-by":"crossref","first-page":"36803","DOI":"10.1074\/jbc.M005912200","volume":"275","author":"AV Bakin","year":"2000","unstructured":"Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L. & Arteaga, C. L. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275, 36803\u201336810 (2000).","journal-title":"J Biol Chem"},{"key":"BFsrep26282_CR17","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1038\/sj.onc.1209091","volume":"24","author":"L Larue","year":"2005","unstructured":"Larue, L. & Bellacosa, A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3\u2032 kinase\/AKT pathways. Oncogene 24, 7443\u20137454 (2005).","journal-title":"Oncogene"},{"key":"BFsrep26282_CR18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/0008-5472.CAN-12-4721","volume":"74","author":"JM Buonato","year":"2014","unstructured":"Buonato, J. M. & Lazzara, M. J. ERK1\/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition. Cancer Res 74, 309\u2013319 (2014).","journal-title":"Cancer Res"},{"key":"BFsrep26282_CR19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","volume":"24","author":"J Caramel","year":"2013","unstructured":"Caramel, J. et al. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell 24, 466\u2013480 (2013).","journal-title":"Cancer Cell"},{"key":"BFsrep26282_CR20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","volume":"11","author":"RJ Akhurst","year":"2012","unstructured":"Akhurst, R. J. & Hata, A. Targeting the TGFbeta signalling pathway in disease. Nat Rev Drug Discov 11, 790\u2013811 (2012).","journal-title":"Nat Rev Drug Discov"},{"key":"BFsrep26282_CR21","doi-asserted-by":"crossref","first-page":"e72252","DOI":"10.1371\/journal.pone.0072252","volume":"8","author":"J Dzieran","year":"2013","unstructured":"Dzieran, J. et al. Comparative analysis of TGF-beta\/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines. PLos One 8, e72252 (2013).","journal-title":"PLos One"},{"key":"BFsrep26282_CR22","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/hep.23769","volume":"52","author":"S Senturk","year":"2010","unstructured":"Senturk, S. et al. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth. Hepatology 52, 966\u2013974 (2010).","journal-title":"Hepatology"},{"key":"BFsrep26282_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/hep.20757","volume":"42","author":"K Herzer","year":"2005","unstructured":"Herzer, K. et al. Transforming growth factor beta can mediate apoptosis via the expression of TRAIL in human hepatoma cells. Hepatology 42, 183\u2013192, doi: 10.1002\/hep.20757 (2005).","journal-title":"Hepatology"},{"key":"BFsrep26282_CR24","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1242\/jcs.115.15.3193","volume":"115","author":"AV Bakin","year":"2002","unstructured":"Bakin, A. V., Rinehart, C., Tomlinson, A. K. & Arteaga, C. L. p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 115, 3193\u20133206 (2002).","journal-title":"J Cell Sci"},{"key":"BFsrep26282_CR25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.molcel.2010.02.020","volume":"38","author":"S Shin","year":"2010","unstructured":"Shin, S., Dimitri, C. A., Yoon, S. O., Dowdle, W. & Blenis, J. ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events. Mol Cell 38, 114\u2013127 (2010).","journal-title":"Mol Cell"},{"key":"BFsrep26282_CR26","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1074\/jbc.275.4.2727","volume":"275","author":"JR Graff","year":"2000","unstructured":"Graff, J. R., Gabrielson, E., Fujii, H., Baylin, S. B. & Herman, J. G. Methylation patterns of the E-cadherin 5\u2032 CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 275, 2727\u20132732 (2000).","journal-title":"J Biol Chem"},{"key":"BFsrep26282_CR27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/sj.bjc.6602996","volume":"94","author":"M Lombaerts","year":"2006","unstructured":"Lombaerts, M. et al. E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer 94, 661\u2013671 (2006).","journal-title":"Br J Cancer"},{"key":"BFsrep26282_CR28","doi-asserted-by":"publisher","first-page":"e884","DOI":"10.1038\/cddis.2013.416","volume":"4","author":"X Chen","year":"2013","unstructured":"Chen, X. et al. The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition of lens epithelial cells. Cell Death Dis 4, e884, doi: 10.1038\/cddis.2013.416 (2013).","journal-title":"Cell Death Dis"},{"key":"BFsrep26282_CR29","doi-asserted-by":"publisher","first-page":"e58672","DOI":"10.1371\/journal.pone.0058672","volume":"8","author":"FS Giudice","year":"2013","unstructured":"Giudice, F. S., Pinto, D. S. Jr., Nor, J. E., Squarize, C. H. & Castilho, R. M. Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer. PLos One 8, e58672, doi: 10.1371\/journal.pone.0058672 (2013).","journal-title":"PLos One"},{"key":"BFsrep26282_CR30","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1158\/0008-5472.CAN-13-0560","volume":"73","author":"I Mikaelian","year":"2013","unstructured":"Mikaelian, I. et al. Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-beta-independent mechanism. Cancer Res 73, 6621\u20136631, doi: 10.1158\/0008-5472.CAN-13-0560 (2013).","journal-title":"Cancer Res"},{"key":"BFsrep26282_CR31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ccr.2012.10.012","volume":"22","author":"OH Ocana","year":"2012","unstructured":"Ocana, O. H. et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22, 709\u2013724, doi: 10.1016\/j.ccr.2012.10.012 (2012).","journal-title":"Cancer Cell"},{"key":"BFsrep26282_CR32","first-page":"487","volume":"28","author":"M Taki","year":"2006","unstructured":"Taki, M., Verschueren, K., Yokoyama, K., Nagayama, M. & Kamata, N. Involvement of Ets-1 transcription factor in inducing matrix metalloproteinase-2 expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Int J Oncol 28, 487\u2013496 (2006).","journal-title":"Int J Oncol"},{"key":"BFsrep26282_CR33","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/ncb2607","volume":"14","author":"R Chakrabarti","year":"2012","unstructured":"Chakrabarti, R. et al. Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2. Nat Cell Biol 14, 1212\u20131222, doi: 10.1038\/ncb2607 (2012).","journal-title":"Nat Cell Biol"},{"key":"BFsrep26282_CR34","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1158\/0008-5472.CAN-12-0212","volume":"72","author":"D Albino","year":"2012","unstructured":"Albino, D. et al. ESE3\/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features. Cancer Res 72, 2889\u20132900, doi: 10.1158\/0008-5472.CAN-12-0212 (2012).","journal-title":"Cancer Res"},{"key":"BFsrep26282_CR35","doi-asserted-by":"publisher","first-page":"15449","DOI":"10.1073\/pnas.1004900107","volume":"107","author":"JH Taube","year":"2010","unstructured":"Taube, J. H. et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 107, 15449\u201315454, doi: 10.1073\/pnas.1004900107 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep26282_CR36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/labinvest.2013.151","volume":"94","author":"H Xiao","year":"2014","unstructured":"Xiao, H. et al. BAG3 regulates epithelial-mesenchymal transition and angiogenesis in human hepatocellular carcinoma. Lab Invest 94, 252\u2013261 (2014).","journal-title":"Lab Invest"},{"key":"BFsrep26282_CR37","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1101\/gad.1809309","volume":"23","author":"M Yu","year":"2009","unstructured":"Yu, M. et al. A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression. Genes Dev 23, 1737\u20131742, doi: 10.1101\/gad.1809309 (2009).","journal-title":"Genes Dev"},{"key":"BFsrep26282_CR38","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","volume":"69","author":"Y Hoshida","year":"2009","unstructured":"Hoshida, Y. et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res 69, 7385\u20137392 (2009).","journal-title":"Cancer Res"},{"key":"BFsrep26282_CR39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1476-4598-9-179","volume":"9","author":"YL Chao","year":"2010","unstructured":"Chao, Y. L., Shepard, C. R. & Wells, A. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer 9, 179 (2010).","journal-title":"Mol Cancer"},{"key":"BFsrep26282_CR40","doi-asserted-by":"crossref","first-page":"18144","DOI":"10.1073\/pnas.1318192110","volume":"110","author":"M Lu","year":"2013","unstructured":"Lu, M., Jolly, M. K., Levine, H., Onuchic, J. N. & Ben-Jacob, E. MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination. Proc Natl Acad Sci USA 110, 18144\u201318149 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep26282_CR41","doi-asserted-by":"crossref","first-page":"328372","DOI":"10.1155\/2012\/328372","volume":"2012","author":"JP Guegan","year":"2012","unstructured":"Guegan, J. P., Fremin, C. & Baffet, G. The MAPK MEK1\/2-ERK1\/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control. Int J Hepatol 2012, 328372 (2012).","journal-title":"Int J Hepatol"},{"key":"BFsrep26282_CR42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1261\/rna.042259.113","volume":"20","author":"A Shilo","year":"2014","unstructured":"Shilo, A. et al. Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development. RNA 20, 505\u2013515 (2014).","journal-title":"RNA"},{"key":"BFsrep26282_CR43","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3892\/ol.2014.2037","volume":"7","author":"Y Sun","year":"2014","unstructured":"Sun, Y., Song, G. D., Sun, N., Chen, J. Q. & Yang, S. S. Slug overexpression induces stemness and promotes hepatocellular carcinoma cell invasion and metastasis. Oncol Lett 7, 1936\u20131940 (2014).","journal-title":"Oncol Lett"},{"key":"BFsrep26282_CR44","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.23221","volume":"50","author":"MH Yang","year":"2009","unstructured":"Yang, M. H. et al. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology 50, 1464\u20131474 (2009).","journal-title":"Hepatology"},{"key":"BFsrep26282_CR45","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/sj.bjc.6601685","volume":"90","author":"A Miyoshi","year":"2004","unstructured":"Miyoshi, A. et al. Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br J Cancer 90, 1265\u20131273 (2004).","journal-title":"Br J Cancer"},{"key":"BFsrep26282_CR46","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.bjc.6602266","volume":"92","author":"A Miyoshi","year":"2005","unstructured":"Miyoshi, A. et al. Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. Br J Cancer 92, 252\u2013258 (2005).","journal-title":"Br J Cancer"},{"key":"BFsrep26282_CR47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/sj.bjc.6600017","volume":"86","author":"W Jiao","year":"2002","unstructured":"Jiao, W., Miyazaki, K. & Kitajima, Y. Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br J Cancer 86, 98\u2013101 (2002).","journal-title":"Br J Cancer"},{"key":"BFsrep26282_CR48","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","volume":"309","author":"BD Lindenbach","year":"2005","unstructured":"Lindenbach, B. D. et al. Complete replication of hepatitis C virus in cell culture. Science (New York, N.Y 309, 623\u2013626 (2005).","journal-title":"Science (New York, N.Y"},{"key":"BFsrep26282_CR49","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nmeth.1325","volume":"6","author":"A Hotta","year":"2009","unstructured":"Hotta, A. et al. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods 6, 370\u2013376 (2009).","journal-title":"Nat Methods"},{"key":"BFsrep26282_CR50","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1074\/jbc.M111.308916","volume":"287","author":"A George","year":"2012","unstructured":"George, A. et al. Hepatitis C virus NS5A binds to the mRNA cap-binding eukaryotic translation initiation 4F (eIF4F) complex and up-regulates host translation initiation machinery through eIF4E-binding protein 1 inactivation. J Biol Chem 287, 5042\u20135058 (2012).","journal-title":"J Biol Chem"},{"key":"BFsrep26282_CR51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/abio.1995.1318","volume":"228","author":"H Fukazawa","year":"1995","unstructured":"Fukazawa, H., Mizuno, S. & Uehara, Y. A microplate assay for quantitation of anchorage-independent growth of transformed cells. Anal Biochem 228, 83\u201390 (1995).","journal-title":"Anal Biochem"},{"key":"BFsrep26282_CR52","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jhep.2013.07.036","volume":"59","author":"N Benzoubir","year":"2013","unstructured":"Benzoubir, N. et al. HCV core-mediated activation of latent TGF-beta via thrombospondin drives the crosstalk between hepatocytes and stromal environment. J Hepatol 59, 1160\u20131168 (2013).","journal-title":"J Hepatol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep26282","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep26282.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep26282.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T14:50:24Z","timestamp":1672843824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep26282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,20]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,19]]}},"alternative-id":["BFsrep26282"],"URL":"https:\/\/doi.org\/10.1038\/srep26282","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,20]]},"assertion":[{"value":"29 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26282"}}